These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26548897)

  • 1. Novel systemic therapies for the treatment of psoriasis.
    Tan KW; Griffiths CE
    Expert Opin Pharmacother; 2016; 17(1):79-92. PubMed ID: 26548897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer treatments of psoriasis regarding IL-23 inhibitors, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors.
    Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Bebenek K; Kaźmierczak A
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28994166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecules: an overview of emerging therapeutic options in the treatment of psoriasis.
    Gooderham M
    Skin Therapy Lett; 2013; 18(7):1-4. PubMed ID: 24305752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
    Gan EY; Chong WS; Tey HL
    BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological basis of systemic treatments in psoriasis.
    Volc S; Ghoreschi K
    J Dtsch Dermatol Ges; 2016 Jun; 14(6):557-72. PubMed ID: 27240060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors.
    Rafael A; Torres T
    Eur J Dermatol; 2016; 26(1):3-8. PubMed ID: 26552963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
    Yiu ZZ; Warren RB
    Am J Clin Dermatol; 2016 Jun; 17(3):191-200. PubMed ID: 26923915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib for the treatment of moderate-to-severe psoriasis.
    Chiricozzi A; Faleri S; Saraceno R; Bianchi L; Buonomo O; Chimenti S; Chimenti MS
    Expert Rev Clin Immunol; 2015 Apr; 11(4):443-55. PubMed ID: 25666451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic development in psoriasis.
    Sobell JM; Leonardi CL
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S69-72. PubMed ID: 25268599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New systemic therapies for psoriasis.
    Mansouri Y; Goldenberg G
    Cutis; 2015 Mar; 95(3):155-60. PubMed ID: 25844781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 targeted therapies for psoriasis.
    Chiricozzi A; Krueger JG
    Expert Opin Investig Drugs; 2013 Aug; 22(8):993-1005. PubMed ID: 23731078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies.
    Campa M; Menter A
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1337-1344. PubMed ID: 27687859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preclinical discovery and development of deucravacitinib for the treatment of psoriasis.
    Coscarella G; Malvaso D; Mannino M; Caldarola G; Fossati B; De Simone C; Chiricozzi A; Peris K
    Expert Opin Drug Discov; 2023; 18(11):1201-1208. PubMed ID: 37574849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New biological drugs in the treatment of inflammatory skin diseases].
    Mälkönen T
    Duodecim; 2014; 130(6):627-34. PubMed ID: 24724461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).
    Chiricozzi A; Saraceno R; Novelli L; Fida M; Caso F; Scarpa R; Costa L; Perricone R; Romanelli M; Chimenti S; Chimenti MS
    Expert Opin Ther Pat; 2016 Jul; 26(7):757-66. PubMed ID: 27266423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and emerging therapies in psoriasis.
    Leonardi CL; Gordon KB
    Semin Cutan Med Surg; 2014 Mar; 33(2 Suppl 2):S37-41. PubMed ID: 24979544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging topical treatments for psoriasis.
    Kivelevitch DN; Hebeler KR; Patel M; Menter A
    Expert Opin Emerg Drugs; 2013 Dec; 18(4):523-32. PubMed ID: 24274614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging systemic drugs in the treatment of plaque psoriasis.
    Balogh EA; Bashyam AM; Ghamrawi RI; Feldman SR
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):89-100. PubMed ID: 32192366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of developing TNF-α targeted therapy for the treatment of psoriasis.
    Campa M; Ryan C; Menter A
    Expert Opin Investig Drugs; 2015; 24(10):1343-54. PubMed ID: 26289788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current investigational drugs in psoriasis.
    Ryan C; Abramson A; Patel M; Menter A
    Expert Opin Investig Drugs; 2012 Apr; 21(4):473-87. PubMed ID: 22400979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.